Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$16.95 - $27.04 $1.96 Million - $3.13 Million
115,704 New
115,704 $3.13 Million
Q4 2023

Feb 14, 2024

BUY
$6.29 - $15.72 $1.25 Million - $3.12 Million
198,362 Added 416.65%
245,971 $3.02 Million
Q3 2023

Nov 14, 2023

BUY
$14.99 - $32.65 $487,219 - $1.06 Million
32,503 Added 215.17%
47,609 $713,000
Q2 2023

Aug 14, 2023

SELL
$29.76 - $46.14 $636,030 - $986,104
-21,372 Reduced 58.59%
15,106 $490,000
Q1 2023

May 15, 2023

SELL
$38.09 - $57.79 $2.02 Million - $3.07 Million
-53,146 Reduced 59.3%
36,478 $1.43 Million
Q4 2022

Feb 14, 2023

BUY
$40.54 - $56.2 $3.35 Million - $4.65 Million
82,733 Added 1200.59%
89,624 $4.74 Million
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $254,829 - $339,037
6,891 New
6,891 $310,000
Q3 2022

Nov 14, 2022

BUY
$36.98 - $49.2 $254,829 - $339,037
6,891 New
6,891 $310,000
Q2 2022

Aug 16, 2022

SELL
$28.03 - $45.8 $378,096 - $617,796
-13,489 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$29.24 - $44.06 $160,322 - $241,580
5,483 Added 68.49%
13,489 $557,000
Q1 2021

May 18, 2021

BUY
$46.31 - $62.7 $370,757 - $501,976
8,006 New
8,006 $405,000
Q4 2020

Feb 17, 2021

SELL
$55.51 - $69.94 $1.46 Million - $1.84 Million
-26,317 Closed
0 $0
Q3 2020

Nov 17, 2020

BUY
$42.19 - $69.61 $370,681 - $611,593
8,786 Added 50.12%
26,317 $1.77 Million
Q1 2020

May 15, 2020

BUY
$23.16 - $47.8 $406,017 - $837,981
17,531 New
17,531 $552,000
Q3 2019

Nov 14, 2019

SELL
$31.65 - $46.94 $171,954 - $255,025
-5,433 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$32.5 - $49.12 $176,572 - $266,868
5,433 New
5,433 $263,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.